Skip to main content
Equibles

Man Group plc

Position in VIR — Vir Biotechnology, Inc.

CIK 1637460 LONDON, X0
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,535,510
-$58,689 QoQ
Shares Held
150,688
-15.3% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 237 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority Sole 53% Shared 0% None 47%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,100,351,284 across 114 Biotechnology names. VIR ranks #69 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 436,956 $272,459,544
2 INCY
Incyte Corp
 952,941 $108,025,391
3 ONC
BeOne Medicines Ltd.
 307,463 $87,617,731
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 139,233 $69,161,207
5 APGE
Apogee Therapeutics, Inc.
 397,000 $52,693,809
6 ALNY
Alnylam Pharmaceuticals, Inc.
 170,907 $51,448,133
7 JAZZ
Jazz Pharmaceuticals plc
 152,877 $36,838,770
8 RVMD
Revolution Medicines, Inc.
 173,439 $32,481,655

All Filings in VIR

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,535,510 150,688
2026-03-31 $1,594,199 177,924
2025-09-30 $402,423 70,477
2025-06-30 $1,294,866 256,918
2025-03-31 $597,397 92,191
2023-09-30 $127,413 13,598
2023-06-30 $7,298,336 297,527
2023-03-31 $7,656,318 329,021
2022-12-31 $1,704,476 67,344
2022-09-30 $3,108,686 161,239
2022-06-30 $8,567,000 336,326
2022-03-31 $4,279,576 166,391
2021-12-31 $2,376,288 56,754
2021-09-30 $575,855 13,232
2021-06-30 $378,616 8,008
2021-03-31 $374,937 7,313
2020-12-31 $458,767 17,131
2020-06-30 $1,614,504 39,407